音的强弱 发表于 2025-3-28 15:38:54

http://reply.papertrans.cn/23/2250/224965/224965_41.png

menopause 发表于 2025-3-28 20:25:44

Book 2022ence can compromise the patient‘s treatment, this work will provide support to professionals working in the field of oncology in assessing each chemotherapy infusion sequence.                The introductory chapters present the definition, indication, and the risks and benefits of polypharmacy in cancer therapy,

侧面左右 发表于 2025-3-29 00:30:04

Combined Therapy for the Treatment of Cancer,d be taken into account when choosing the best combination for the treatment of a particular cancer. Finally, I discuss the toxicity profiles of the treatment of various cancers, such as toxicity related to the treatment of breast, lung, colorectal, prostate, cervix, and head and neck cancers.

BLAZE 发表于 2025-3-29 03:25:34

http://reply.papertrans.cn/23/2250/224965/224965_44.png

crease 发表于 2025-3-29 07:34:12

http://reply.papertrans.cn/23/2250/224965/224965_45.png
页: 1 2 3 4 [5]
查看完整版本: Titlebook: Chemotherapy Protocols and Infusion Sequence; Schedule Considerati Iago Dillion Lima Cavalcanti Book 2022 The Editor(s) (if applicable) and